InflaRx (IFRX) Assets (2016 - 2026)
InflaRx (IFRX) posted Assets of $57.2 million for Q1 2026, down 10.95% sequentially from $64.3 million in Q4 2025, and down 37.45% YoY from $91.5 million in Q1 2025.
InflaRx (IFRX) Assets (2016 - 2026) Analysis & Trends
InflaRx has reported Assets for 11 years, with the latest figure at $57.2 million in Q1 2026.
- Quarterly Assets fell 37.45% year-over-year to $57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.2 million (down 37.45% YoY) and the FY2025 annual result came in at $62.4 million, down 24.18% from the prior year.
- Assets declined to $57.2 million in Q1 2026 per IFRX's latest filing, from $64.3 million in the prior quarter.
- Over five years, Assets peaked at $144.8 million in Q2 2023 and troughed at $57.2 million in Q1 2026.
- A 5-year average of $102.0 million and a median of $100.2 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets grew 25.81% in 2023, then sank 37.91% in 2024.
- Over 5 years, Assets stood at $104.5 million in 2022, then grew by 23.8% to $129.3 million in 2023, then plunged by 37.19% to $81.2 million in 2024, then retreated by 20.88% to $64.3 million in 2025, then decreased by 10.95% to $57.2 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $57.2 million, $64.3 million, and $76.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | 194.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.24 Mn |
| Dec 31, 2025 | 64.27 Mn |
| Sep 30, 2025 | 76.17 Mn |
| Jun 30, 2025 | 83.13 Mn |
| Mar 31, 2025 | 91.51 Mn |
| Dec 31, 2024 | 81.23 Mn |
| Sep 30, 2024 | 87.51 Mn |
| Jun 30, 2024 | 100.19 Mn |
| Mar 31, 2024 | 116.34 Mn |
| Dec 31, 2023 | 129.34 Mn |
| Sep 30, 2023 | 140.96 Mn |
| Jun 30, 2023 | 144.79 Mn |
| Mar 31, 2023 | 92.64 Mn |
| Dec 31, 2022 | 104.47 Mn |
| Sep 30, 2022 | 112.04 Mn |
| Jun 30, 2022 | 122.32 Mn |
| Mar 31, 2022 | 129.16 Mn |
| Dec 31, 2021 | 143.16 Mn |
| Sep 30, 2021 | 152.57 Mn |
| Jun 30, 2021 | 162.61 Mn |